BioSpace News Archive

Sesen Bio and Qilu Pharmaceutical Announce IND Application for Vicineum ™ Accepted for Review by the National Medical Products Administration in China Clinical trial expected to be initiated shortly after NMPA approval of the IND Sesen Bio to receive $3M milestone payment upon IND approval

SCHOTT continues to produce record-breaking numbers of pharmaceutical containers, including critical glass vials, as the U.S. prepares for COVID-19 vaccine distribution.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a medical dermatology company developing innovative treatments for patients with immune-mediated dermatological diseases and conditions, today announced that it has commenced pivotal Phase 3 clinical trials evaluating topical roflumilast cream (ARQ-151) as a potential treatment for atopic dermatitis (AD)

Celularity Inc., a clinical-stage cell therapeutics company focused on the development of innovative allogeneic placenta-derived cellular therapies, today announced that its Lifebank division has released its 100th cord blood stem cell unit for use in an autologous cord blood transplant to treat an eight-year-old patient diagnosed with autism spectrum disorder.

AstraZeneca will present new data from across the innovative lung cancer portfolio at the IASLC 2020 World Conference on Lung Cancer (WCLC), hosted by the International Association for the Study of Lung Cancer, 28 to 31 January 2021.

HealthTronics, an Austin-based provider of integrated, mobilized medical technologies and services, has named Bill Linder its new Chief Executive Officer.

Samsung Biologics (207940.KS) set forth its dynamic growth plan for the next decade at the 2021 Annual JP Morgan Healthcare Conference. John Rim , newly appointed President and CEO, unveiled a multidimensional business plan for the company to further expand as a major player in the biopharmaceutical industry, bolstering its

Tyson Foods, Inc. is partnering with Matrix Medical Network ® (Matrix) to ensure the company’s U.S. team members are educated about and have access to the COVID-19 vaccines. Matrix will collaborate with Tyson Foods’ health services team to deploy mobile health clinics and expert clinical staff to support vaccine communication

La Jolla, California--(Newsfile Corp. - January 13, 2021) - Tryp Therapeutics, a leading pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, announced today it has been invited to present at two upcoming industry conferences in January and February 2021.

Vestibular First, a Philadelphia -based health-tech startup, is hosting a Live Streaming Launch Event on January 21st, 2021 for its patented Insight Infrared Video Goggles . These new FDA cleared goggles help clinicians cost-effectively differentiate various causes of dizziness and balance disorders. Vestibular First has identifi